Format

Send to

Choose Destination
See comment in PubMed Commons below
Br J Haematol. 2009 Jan;144(2):230-3. doi: 10.1111/j.1365-2141.2008.07446.x. Epub 2008 Nov 19.

Desmopressin responsiveness in children with Ehlers-Danlos syndrome associated bleeding symptoms.

Author information

  • 1Department of Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH 43205-2696, USA.

Abstract

Ehlers-Danlos Syndrome (EDS) is caused by heritable collagen defects and may be associated with bleeding symptoms. Desmopressin has been described in case reports to decrease bleeding times in these patients. This study sought to assess bleeding time responsiveness to desmopressin therapy in a cohort of children with EDS-associated bleeding manifestations. A retrospective chart review of children with EDS referred for bleeding symptoms was utilized. Twenty-six children were included; 19 (73%) had a desmopressin challenge. The mean bleeding time was 11.26 (+/-4.39) min, decreasing to 5.95 (+/-2.41) min with treatment (P < 0.01). Desmopressin normalizes bleeding times in children with EDS.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center